医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Arthur D. Little Issues Insights on Genetic Testing’s Rapid Growth and Industry-Wide Impact

2017年10月31日 PM08:00
このエントリーをはてなブックマークに追加


 

BOSTON

Arthur D. Little, a consultancy known for strategic thinking, innovative insight and expertise in technology-intensive and emerging industries, today issued a report covering the future of diagnostics and the growth potential of personal genetics services.

The report, “Future of Diagnostics – Personal Genetic Services Due for Explosive Growth,” identifies genetic services companies as disruptive forces that are consumerizing genomic testing and driving rapid transformation of a soon to become $18 billion global industry. Pharmaceutical companies, payers, providers and medtech companies will be impacted by the shift.

In an outcomes-based quality care environment, access to genetic information is critical to the effectiveness of treatments. According to the report, the emerging testing technology means manufacturers can enhance clinical trials, payers can be selective in authorizing treatment payouts, and patients can have more confidence in outcomes.

“Genetic analysis has moved from the domain of the healthcare practitioner to that of the consumer,” writes Craig Wylie, partner at Arthur D. Little. “We expect that a new, consumer-oriented industry will develop that will help individuals know and manage their risks…we also expect continued introduction of new assays going beyond mutation-based biomarkers to actionable biomarkers for an increasing number of conditions.”

The report includes recommendations on how key players should adjust to a consumer-centric genetic information age, as well as analysis of how genetic information enhances more precise care options when addressing life-threatening and incurable diseases.

Access the report: www.adl.com/Futureofdiagnostics

About Arthur D. Little

Arthur D. Little has been at the forefront of innovation since 1886. We are an acknowledged thought leader in linking strategy, innovation and transformation in technology-intensive and converging industries. We navigate our clients through changing business ecosystems to uncover new growth opportunities. We enable our clients to build innovation capabilities and transform their organization.

Our consultants have strong practical industry experience combined with excellent knowledge of key trends and dynamics. Arthur D. Little is present in the most important business centers around the world. We are proud to serve most of the Fortune 1000 companies, in addition to other leading firms and public-sector organizations.

For further information, please visit www.adlittle.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20171031005068/en/

CONTACT

Arthur D. Little
United States Media:
Kristina
Markos
Longview Strategies
Kmarkos@Longviewstrategies.com
978.225.9251
or
Europe/Japan
Media:

Cate Bonthuys
Catalyst Comms
+44-7746546773
cate@catalystcomms.co.uk

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Takeda Announces Information Related to its Pending Voluntary and Conditional Public Takeover Bid for Outstanding Shares and American Depositary Shares of TiGenix
  • Prota/MCRI Completes Enrolment of Phase 2b Multicentre Clinical Trial of Probiotic Oral Immunotherapy for the Treatment of Peanut Allergy (PPOIT-003)
  • Dr. Reddy’s Q4 and FY18 Financial Results
  • 武田薬品が米国臨床腫瘍学会(ASCO)と欧州血液学会(EHA)の年次総会でオンコロジーの広範なポートフォリオとパイプラインのデータを発表
  • ResMed赞助的研究显示,采用居家吸氧与居家无创通气相结合治疗COPD具有成本效益